Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Lyxor UCITS Stoxx Europe 600 Health Care (LYXHEA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
146.61 -0.67    -0.46%
11:35:08 - Closed. Currency in EUR ( Disclaimer )
Type:  ETF
Market:  France
Issuer:  Lyxor
ISIN:  LU1834986900 
Underlying:  STXE Health Care NR
Asset Class:  Equity
  • Volume: 1,097
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 145.63 - 147.27
Lyxor UCITS Stoxx Europe 600 Health Care 146.61 -0.67 -0.46%

LYXHEA Recent Sentiments

 
Information on users’ sentiments for the Lyxor UCITS Stoxx Europe 600 Health Care ETF, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Apr 16, 2024 gautier BAIS   143.80 Apr 22, 2024 @ 145.09 +0.90%
Feb 23, 2024 Olivier Renaud   144.61 Mar 15, 2024 @ 145.92 +0.91%
Feb 02, 2024 Jean Paul RAIMOND   139.94 Feb 23, 2024 @ 144.38 +3.17%
Feb 02, 2024 Thierry Loney   140.46 Feb 05, 2024 @ 140.95 +0.35%
Jan 25, 2024 Maxime Baux   138.19 Feb 16, 2024 @ 142.40 +3.05%
Apr 25, 2023 Mostrador Gérard   139.85 Nov 30, 2023 @ 131.15 -6.22%
Apr 25, 2023 Silvano Orsi   139.90 Nov 30, 2023 @ 131.15 -6.25%
Feb 17, 2023 Mathis Trade   127.58 Mar 10, 2023 @ 124.45 -2.45%
Jan 10, 2023 Maxens DE BARROS   128.55 Feb 03, 2023 @ 126.00 -1.98%
Nov 02, 2022 Juan Carlos Arias...   125.54 Nov 02, 2022 @ 125.54 0.00%
Nov 02, 2022 Juan Carlos Arias...   125.54 Nov 02, 2022 @ 125.54 0.00%
Sep 28, 2022 Juan Carlos Arias...   117.27 Sep 28, 2022 @ 117.27 0.00%
Apr 11, 2022 Nathan Le Sourne   142.34 May 06, 2022 @ 129.49 -9.03%
Jan 20, 2022 julien Bruhat   127.45 Feb 11, 2022 @ 123.07 -3.44%
Dec 24, 2021 julien Bruhat   132.78 Jan 14, 2022 @ 126.61 -4.65%
Nov 15, 2021 Bruno FABRE   132.37 Dec 10, 2021 @ 130.01 -1.78%
Oct 20, 2021 Henri Fisch   126.66 Nov 12, 2021 @ 132.08 +4.28%
Oct 15, 2021 Acerise BERNARD   124.98 Nov 05, 2021 @ 132.00 +5.62%
Sep 03, 2021 Acerise BERNARD   130.00 Sep 24, 2021 @ 125.27 -3.64%
Jul 20, 2021 Acerise BERNARD   122.16 Aug 13, 2021 @ 128.39 +5.10%
May 06, 2021 proxipose proxipose   111.78 May 28, 2021 @ 114.84 +2.74%
May 06, 2021 Albin Milongo   111.59 May 28, 2021 @ 114.84 +2.91%
Feb 04, 2021 Richard Haddad   110.08 Feb 26, 2021 @ 104.50 -5.07%
Feb 01, 2021 Juliux Juju   108.87 Feb 26, 2021 @ 104.50 -4.01%
Jan 04, 2021 Juliux Juju   108.46 Jan 29, 2021 @ 107.36 -1.01%
Dec 28, 2020 Antoine Bogle   106.30 Jan 22, 2021 @ 111.38 +4.78%
Nov 19, 2020 Belkheir SAD   106.88 Dec 11, 2020 @ 106.74 -0.13%
Nov 17, 2020 Niklas Marchner   108.15 Nov 17, 2020 @ 108.15 0.00%
Nov 11, 2020 David Tollard   110.05 Nov 12, 2020 @ 109.57 -0.44%
Oct 14, 2020 Acerise BERNARD   110.55 Nov 06, 2020 @ 108.62 -1.75%
Jul 17, 2020 jj ca   114.38 Aug 07, 2020 @ 108.41 -5.22%
May 14, 2020 Maxime Gaudiau   111.94 Jun 05, 2020 @ 111.58 -0.32%
Apr 29, 2020 Maximilien Duvauchell   110.82 May 22, 2020 @ 113.00 +1.97%
Apr 24, 2020 Maximilien Duvauchell   110.44 Apr 24, 2020 @ 110.44 0.00%
Dec 19, 2019 Frans Coninckx   107.85 Jan 10, 2020 @ 110.80 +2.73%
Oct 15, 2019 Gong YiXi   99.49 Nov 08, 2019 @ 103.81 +4.34%
May 22, 2019 Florian Vittoz   92.13 Jun 14, 2019 @ 94.32 +2.38%
Nov 13, 2018 Gurkan Yilmaz   87.96 Dec 13, 2018 @ 89.47 +1.72%
Nov 08, 2018 Daniel Albalate   88.55 Nov 08, 2018 @ 88.55 0.00%
Oct 09, 2018 Sa Bo   86.21 Oct 10, 2018 @ 85.91 -0.35%
Aug 23, 2018 Paolo Giambruno   90.09 Sep 22, 2018 @ 87.57 -2.80%
Mar 09, 2018 Sa Bo   80.00 Apr 08, 2018 @ 80.02 +0.02%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

LYXHEA Comments

Write your thoughts about Lyxor UCITS Stoxx Europe 600 Health Care
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email